Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Mohammed Hasan Khan

Continuous Outpatient Intravenous Inotrope Therapy: Milrinone Is Associated With Improved Survival Compared to Dobutamine Irrespective of Indication

Journal of Cardiac Failure

Cardiovascular Medicine

Cardiology

2019

English

Related publications

Outcomes and Survival on Long Term Intravenous Inotrope Therapy: A Single Center Experience

Journal of Cardiac Failure

Cardiovascular Medicine

Cardiology

2017

English

Stereotactic Body Radiation Therapy Is Associated With Improved Overall Survival Compared to Chemoradiation or Radioembolization in the Treatment of Unresectable Intrahepatic Cholangiocarcinoma

Clinical and Translational Radiation Oncology

English

High‐Intensity Statin Therapy Is Associated With Improved Survival in Patients With Peripheral Artery Disease

Journal of the American Heart Association

Cardiovascular Medicine

Cardiology

2017

English

Breas-Conserving Therapy Is Associated With Improved Overall Survival Compared to Mastectomy in Women With Stage pT1-2N0M0 Breast Cancer: A National Cancer Data Base Analysis

International Journal of Radiation Oncology Biology Physics

English

Palliative Outpatient Inotrope in End Stage Heart Failure Patients Is Safe With Moderate Survival Benefit: A Single Center Retrospective Study

Journal of Cardiac Failure

Cardiovascular Medicine

Cardiology

2019

English

Chemoradiation Therapy in Unresected Extrahepatic Cholangiocarcinoma Is Associated With Improved Overall Survival Compared to Chemotherapy Alone: A Propensity Score Matched Analysis From the National Cancer Database

International Journal of Radiation Oncology Biology Physics

English

Multi-Agent Induction Chemotherapy Followed by Chemoradiation Is Associated With Improved Survival Compared to Chemotherapy Alone in Locally Advanced Pancreatic Cancer

International Journal of Radiation Oncology Biology Physics

English

The Addition of Postoperative Chemotherapy Is Associated With Improved Survival in Patients With Pancreatic Cancer Treated With Preoperative Therapy

Annals of Surgical Oncology

Oncology

Surgery

2015

English

Maintenance Rituximab Is Associated With Improved Overall Survival in Mantle Cell Lymphoma Patients Responding to Induction Therapy With Bendamustine + Rituximab (Br)

Hematological Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Mohammed Hasan Khan

Continuous Outpatient Intravenous Inotrope Therapy: Milrinone Is Associated With Improved Survival Compared to Dobutamine Irrespective of Indication

Related publications

Outcomes and Survival on Long Term Intravenous Inotrope Therapy: A Single Center Experience

Stereotactic Body Radiation Therapy Is Associated With Improved Overall Survival Compared to Chemoradiation or Radioembolization in the Treatment of Unresectable Intrahepatic Cholangiocarcinoma

High‐Intensity Statin Therapy Is Associated With Improved Survival in Patients With Peripheral Artery Disease

Breas-Conserving Therapy Is Associated With Improved Overall Survival Compared to Mastectomy in Women With Stage pT1-2N0M0 Breast Cancer: A National Cancer Data Base Analysis

Palliative Outpatient Inotrope in End Stage Heart Failure Patients Is Safe With Moderate Survival Benefit: A Single Center Retrospective Study

Chemoradiation Therapy in Unresected Extrahepatic Cholangiocarcinoma Is Associated With Improved Overall Survival Compared to Chemotherapy Alone: A Propensity Score Matched Analysis From the National Cancer Database

Multi-Agent Induction Chemotherapy Followed by Chemoradiation Is Associated With Improved Survival Compared to Chemotherapy Alone in Locally Advanced Pancreatic Cancer

The Addition of Postoperative Chemotherapy Is Associated With Improved Survival in Patients With Pancreatic Cancer Treated With Preoperative Therapy

Maintenance Rituximab Is Associated With Improved Overall Survival in Mantle Cell Lymphoma Patients Responding to Induction Therapy With Bendamustine + Rituximab (Br)